ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Electronic Technology

Shimadzu Corp.

Business Summary

Shimadzu Corp. engages in the manufacture and sale of testing, measuring, medical, aircraft and analytical instruments. It operates through the following segments: Analytical Instruments, Medical Systems, Aircraft Equipment, Industrial Machinery & Equipment, and Others. The Analytical Instruments segment handles the general analytical and environmental measurement instruments such as mass spectrometers, chromatographs, spectrophotometers, surface analysis and observation systems, water quality analyzers, and continuous emission monitoring systems. The Medical System segment offers diagnostic systems and services to medical facilities such as fluoroscopy, angiography, radiography, near-infrared imaging, and medical information systems. The Aircraft Equipment segment provides aircraft and ground support equipment which includes flight control, air management, cockpit display systems, aircraft equipment functional testers, and aircraft medical training equipment. The Industrial Machinery & Equipment segment offers advanced-level manufacturing and testing equipment for the industrial field such as turbo molecular pumps, anti-reflective coating systems for solar cells, hydraulic gear pumps, power packages, diffraction gratings, and laser modules. The Others segment handles the leasing and management of real estate, software development, product design, and pavement construction business. The company was founded by Genzo Shimadzu Sr. on March 31, 1875 and is headquartered in Kyoto, Japan.

Financial Highlights

Mar 2021 JPYUSD
Revenue393,499M3,710.24M
Gross Profit156,193M1,472.72M
Operating income49,743M469.01M
Income before tax49,817M469.71M
Net income36,097M340.35M
EBITDA65,483M617.42M
Diluted EPS122.511.15
Dividends Per Share340.32
Total Assets497,459M4,501.89M
Total liabilities161,951M1,465.61M
Total equity335,504M3,036.23M
Operating cash flow63,801M601.57M
Currency in JPYCurrency in USD

Historical Data

 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 342,479M 376,530M 391,213M 385,443M 393,499M
Gross Profit 136,409M 149,833M 157,169M 152,430M 156,193M
Operating income 37,090M 42,822M 44,481M 41,846M 49,743M
Income before tax 36,113M 41,775M 44,652M 43,113M 49,817M
Net income 26,473M 29,838M 32,524M 31,765M 36,097M
EBITDA 46,673M 53,460M 56,117M 55,258M 65,483M
Diluted EPS 89.79 101.26 110.40 107.83 122.51
Dividends Per Share 20 24 28 30 34
Total Assets 375,354M 418,548M 437,190M 437,618M 497,459M
Total liabilities 133,722M 150,484M 149,246M 134,840M 161,951M
Total equity 241,332M 267,694M 287,894M 302,775M 335,504M
Operating cash flow 29,608M 41,215M 29,454M 39,509M 63,801M
 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 3,162.68M 3,397.29M 3,527.78M 3,545.09M 3,710.24M
Gross Profit 1,259.69M 1,351.88M 1,417.28M 1,401.96M 1,472.72M
Operating income 342.51M 386.36M 401.11M 384.87M 469.01M
Income before tax 333.49M 376.92M 402.65M 396.52M 469.71M
Net income 244.46M 269.21M 293.28M 292.15M 340.35M
EBITDA 431.01M 482.34M 506.03M 508.23M 617.42M
Diluted EPS 0.82 0.91 0.99 0.99 1.15
Dividends Per Share 0.18 0.21 0.25 0.27 0.32
Total Assets 3,368.51M 3,935.57M 3,949.85M 4,053.70M 4,501.89M
Total liabilities 1,200.05M 1,414.98M 1,348.38M 1,249.03M 1,465.61M
Total equity 2,165.77M 2,517.10M 2,601.02M 2,804.64M 3,036.23M
Operating cash flow 273.42M 371.86M 265.60M 363.38M 601.57M

Valuation Measures

Mar 2021
PER32.68
ROA7.72%
ROE11.31%
Operating margin12.64%
Profit margin9.17%

Key executives

  • President, CEO & Representative Director: Teruhisa Ueda
  • Manager-Finance & Accounting: Shin Bandai
  • Head-Information Systems & Manufacturing: Yasunori Yamamoto
  • Executive Officer: Koyoshi Aoyama
  • Executive Officer & Manager-Legal Affairs: Kenichiro Hirata

Shareholders

  • Meiji Yasuda Life Insurance Co. (7.0%)
  • Mitsubishi UFJ Financial Group, Inc. (4.0%)
  • MFS International (UK) Ltd. (3.6%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.4%)
  • Nomura Asset Management Co., Ltd. (3.0%)
  • T&D Holdings, Inc. (2.5%)
  • The Vanguard Group, Inc. (2.1%)
  • Tokio Marine Holdings, Inc. (2.1%)
  • Nikko Asset Management Co., Ltd. (1.7%)
  • FIL Investments (Japan) Ltd. (1.7%)

Contact Details

  • Website:http://www.shimadzu.co.jp
  • Address: 1 Nishinokyo Kuwabara-cho, Nakagyo-Ku, Kyoto, 604-8511, Japan
  • Phone: +81.75.823.1111

Related Companies

  • Shimadzu Manufacturing Asia Sdn. Bhd.
  • Shimadzu Software Development Canada, Inc.
  • Shimadzu Research Laboratory (Shanghai) Co., Ltd.
  • Shimazu Board Incentive Plan
  • Shimadzu (Guangzhou) Analysis & Technology Services Co. Ltd.
  • Shimadzu Latin America SA
  • Shimadzu Medical Systems (Oceania) Pty Ltd.
  • Shimadzu Korea Vacuum Equipment Co. Ltd.
  • Beijing Shimadzu Medical Equipment Co., Ltd.
  • Shimadzu Scientific Instruments (Taiwan) Co. Ltd.
  • Shimadzu Scientific Instruments (Oceania) Pty Ltd.
  • Shimadzu (China) Co., Ltd.
  • SHIMADZU Philippines Corp.
  • Shimadzu Medical India Pvt. Ltd.
  • Shimadzu do Brasil Comercio Ltda.
  • Shimadzu Research Laboratory (Europe) Ltd.
  • Shimadzu Middle East & Africa FZE
  • Shimadzu South Africa (Pty) Ltd.
  • Shimadzu Taiwan Industrial Machinery Co. Ltd.
  • Shimadzu International Trading (Shanghai) Co. Ltd.
  • Shimadzu Scientific Instruments, Inc. (Pennsylvania)
  • Shimadzu Scientific Instruments, Inc. (Texas)
  • Shimadzu (Hong Kong) Ltd.
  • Medical Imaging Technologies Pty Ltd.
  • Shimadzu Trust
  • Shimadzu Medical Systems USA
  • Shimadzu (Asia Pacific) Pte Ltd.
  • Shimadzu Medical Systems Corp.
  • Shimadzu Device Corp.
  • Shimadzu Precision TechnologyLtd

Competitors

  • Agilent Technologies, Inc.
  • Waters Corporation
  • Bruker Corporation
  • Atlas Copco AB Class A
  • II-VI Incorporated
  • 908 Devices Inc.
  • Beijing SDL Technology Co., Ltd. Class A
  • Concentric AB
  • Accelerate Diagnostics, Inc.
  • Bio-Techne Corporation
  • Vuzix Corporation
Last Updated on 5 Aug, 2021

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more